Lead Product(s) : N-Iodoallyl-2-Carbomethoxy-3-4-Fluorophenyl-Tropane
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Fortrea
Deal Size : Inapplicable
Deal Type : Inapplicable
Altropane Dose for Imaging Patients With Suspected Parkinson's Disease
Details : Altropane is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Parkinson Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 05, 2022
Lead Product(s) : N-Iodoallyl-2-Carbomethoxy-3-4-Fluorophenyl-Tropane
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Fortrea
Deal Size : Inapplicable
Deal Type : Inapplicable